Clinical Trial Update: Study of Swine-Origin A/H1N1 Influenza Non-Adjuvanted Vaccine in Healthy Adults in India [Phase 3]

View source ↗

Summary

Phase 3 study evaluating a swine-origin A/H1N1 influenza non-adjuvanted vaccine in healthy adults in India has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Influenza Virus Infection H1n1 Subtype
• Pandemic Influenza

Drugs mentioned

• A/H1N1 influenza non-adjuvanted vaccine (swine-origin) (Influenza A/H1N1 vaccine, non-adjuvanted)

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Influenza, Pandemic Influenza | Phase 3 | Status: COMPLETED